You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced non-clear cell renal cell cancer (RCC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in United States (everolimus and bevacizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • everolimus and bevacizumab
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

Not yet recruiting
  • Advanced Cancer
  • Clear Cell Renal Cell Carcinoma
  • 177Lu girentuximab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
Dec 15, 2022

Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Ipilimumab plus nivolumab
  • Standard Therapy
  • Gent, Belgium
  • +40 more
Feb 7, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

Not yet recruiting
  • Advanced Clear Cell Renal Carcinoma (Ccrcc)
  • Papillary Renal Cell Carcinoma (Prcc)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

Recruiting
  • Advanced Renal Cell Carcinoma
  • ST-1898 tablets
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Nov 6, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2022

Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

Recruiting
  • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
  • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
  • Shanghai, Shanghai, China
    Shanghai Renji Hospital
Sep 12, 2023

Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pucotenlimab Combined With Lenvatinib
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen University Cancer Center
Nov 10, 2023

Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

Recruiting
  • Non-Clear Cell Renal Cell Carcinoma
  • Duarte, California
    Exelixis Clinical Site #1
Jan 13, 2023

Renal Cell Carcinoma Trial (HS-10516)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Sep 24, 2023

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

Available
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-DFO-girentuximab
  • Los Angeles, California
    UCLA
Oct 12, 2023

Advanced Clear Cell Renal Cell Carcinoma Trial (6MW3211)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • (no location specified)
Aug 14, 2022

RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

Not yet recruiting
  • RCC
  • Renal Cell Carcinoma
  • Cabozantinib 80 MG
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 3, 2023

First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

Not yet recruiting
  • First-line Treatment of Non-clear Renal Cell Carcinoma
  • Fruquintinib combined with Serplulimab
  • (no location specified)
Apr 16, 2023

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

Active, not recruiting
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Salzburg, Austria
  • +39 more
Jan 18, 2023

Carcinoma, Renal Cell Trial in United States (Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +3 more
Jan 27, 2023

Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

Recruiting
  • Advanced Renal Cell Carcinoma
  • IVAC
  • Heilbronn, Germany
    SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022